• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Alterity Therapeutics Releases Q1 FY26 Cash Flow Report

    GLOBENEWSWIRE

    Alterity Reveals Positive ATH434 Ph 2 Trial Results At Congress

    GLOBENEWSWIRE

    Alterity Therapeutics To Present At 2025 Parkinson`s Disease

    GLOBENEWSWIRE

    Alterity Therapeutics Presents New Data from ATH434 Phase 2 Trial

    GLOBENEWSWIRE

    Alterity Therapeutics to Present Positive ATH434 Phase 2 Results

    GLOBENEWSWIRE

    Alterity Reports Positive Interim Data For ATH434 In MSA Trial

    GLOBENEWSWIRE

    Alterity Shows ATH434 Potential in Friedreich`s Ataxia

    GLOBENEWSWIRE

    Alterity Therapeutics Presents New Data at World Orphan Drug Congress

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.